Brain Cancer Clinical Trials in Cleveland

Showing 61-80 of 100 trials

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

NCT00369785

RATIONALE: Donepezil may help lessen confusion and fatigue and improve mood and quality of life in patients who have undergone radiation therapy for brain tumors. It is not yet known whether donepezil is more effective than a placebo in lessening side effects of radiation therapy in patients with brain tumors. PURPOSE: This randomized phase III trial is studying donepezil to see how well it works in lessening side effects of radiation therapy compared with a placebo in patients who have undergone radiation therapy for brain tumors.

Brain TumorsMetastatic Disease

Wake Forest University Health Sciences198 participantsStarted Feb 2008

Wichita, Kansas, United States • Wichita, Kansas, United States • Wichita, Kansas, United States +13 more locations

COMPLETEDPHASE2< 1 mile

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

NCT02844439

This is a multicenter, Phase 2 study to assess the activity of tesevatinib in patients with recurrent glioblastoma.

GlioblastomaRecurrent GlioblastomaBrain Tumor

Kadmon Corporation, LLC40 participantsStarted Jun 2016

Tucson, Arizona, United States • Duarte, California, United States • San Francisco, California, United States +8 more locations

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

Brain Cancer Trials in Other Cities

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM

Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor

Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme

Radiosurgery Plus Bevacizumab in Glioblastoma

Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas

A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

UNITE Study: Understanding New Interventions With GBM ThErapy

Gliogene: Brain Tumor Linkage Study

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma

First in Patient Study for PF-06840003 in Malignant Gliomas

Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme

Other Conditions in Cleveland